Stefan Bauer

Stefan Bauer runs a company that turns a process which used to take forty-plus hours and cost roughly $14,000 into something that fits inside a two-day remote appointment for about $1,000. That is the entire business case for Marker Learning, and it is blunt enough that a school superintendent, after watching a handful of trial evaluations run through the platform, called back the following month and asked for one hundred more. Bauer tells that story the way other founders tell you about their app store ranking. It is the proof point that made venture capitalists start returning his emails.

Before any of this, Bauer worked in fixed income sales and trading at Morgan Stanley, from 2011 to 2014, then moved into leveraged finance there in 2015. He went to Yale School of Management for his MBA, graduating in 2016, then spent years at McKinsey & Company as an Associate and later an Engagement Manager, running digital strategy projects for corporate clients. None of that is a typical prelude to running a healthtech startup focused on learning disability evaluations. It is, however, a very typical prelude to running any startup with a clean unit economics story, and Marker Learning has one: cut the cost, cut the wait, keep the clinical rigor, sell to both individual families and entire school districts at once.

He co-founded the company in 2021 with Emily Yudofsky, a fellow Yale alumna. The two built a platform that pairs students with licensed psychologists for remote assessments identical in structure to the in-person version, just compressed and digitized. Within five months of launching, the company had raised a $4 million seed round led by Divergent Ventures, Operator Partners, and Primary Ventures, and was already operating in seven states. Jason Shuman, a partner at Primary Ventures, put the underlying math plainly at the time: roughly 20% of children in the U.S. have a learning disability, and roughly 4% get diagnosed. That gap is the whole opportunity, stated in two numbers.

Eighteen months later, in February 2023, Marker Learning closed a $15 million Series A led by Andreessen Horowitz. The round's investor list reads a little unusually for a specialized evaluation platform: Virgin Group, the venture arm of Richard Branson's holding company, joined alongside existing backers Primary Ventures, Difference Partners, Operator Partners, and Night Ventures. Strategic investors included NBA champion Danny Green, creative director La Mar Taylor, and two-time WNBA champion Jewell Loyd. It is not the typical cap table for a company whose product is a psychological assessment, and that is part of what made the round notable — Bauer built something that professional athletes and a British billionaire's investment arm both wanted a piece of, for reasons that had nothing to do with novelty and everything to do with the underlying numbers.

Total funding now sits at $19.7 million. The company has grown to 58 employees and has been recognized by Built In as one of the best places to work in New York City for consecutive years — a detail that matters less for the accolade itself than for what it signals about retention in a company built around clinical staffing, where licensed psychologists are the actual product being scaled.

Bauer's own account of why he built this company traces back to childhood difficulty with reading, and a private evaluation his family paid for that changed the trajectory of his education. He has spoken about it publicly — on a TechCrunch podcast, in a Bloomberg Equality segment, on Yale School of Management's own startup features — but the way he tells it is notably unsentimental. He does not linger on the diagnosis. He moves quickly to the systemic point: that access to this kind of evaluation has historically depended on a family's ability to pay several thousand dollars out of pocket and wait months for an appointment, and that the entire model breaks down for anyone without the Baur family's resources. "While 20% of students have dyslexia, only 5% get properly diagnosed in the U.S.," he has said, framing his own experience as a data point rather than a confession.

That framing — personal story converted almost immediately into a market statistic — is a useful window into how Bauer operates as a founder. He spent his twenties inside institutions built to price risk and structure deals. Marker Learning is, in a sense, the same skill set redirected: identify a mispriced good (evaluation access), find the bottleneck (licensed psychologist capacity, geographic limits, cost), and build infrastructure that removes the bottleneck without compromising the underlying quality of the assessment itself. The company's pitch decks probably look more like a Morgan Stanley research note than a typical consumer health startup's, and that may be exactly the point.

At Yale, Bauer has said his MBA classmates were one of his most valuable resources while getting Marker Learning off the ground — he has described consulting more than thirty of them for feedback on business plans, funding approaches, and growth strategy before the company had a product to show anyone else. That is a fairly literal use of a business school network, treated less as a credential and more as a working advisory board.

The company's growth so far has followed a fairly conventional venture trajectory — seed, then Series A, then headcount growth, then workplace recognition — but the market it operates in is not conventional venture territory. Special education evaluation is a fragmented, licensure-heavy, state-regulated field that most software companies avoid precisely because it resists the kind of scaling venture capital rewards. Bauer's bet is that digitizing the clinician relationship, rather than trying to automate around it, is the way through. So far, the funding rounds and the superintendent phone calls suggest investors and school administrators both think that bet is a reasonable one.